Prognyx oncology intelligence

Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.

我該用這個嗎

品質與安全性

A
說明品質
100%
結構描述完整度
97%
命名品質
93%
汙染風險
100%
權限相符程度
100%
協定合規性
100%

根據工具定義與協定合規性的自動化分析。

上下文成本

~568Token(工具定義)
~951 B典型回應大小
極小的注意力影響(128k 上下文的 0.44%)

這是每次將伺服器的工具載入模型上下文時所消耗的約略 token 數量。數量越高,可用於其他工作的注意力就越少。

安裝

一鍵安裝

將以下內容加入你的 `claude_desktop_config.json` 檔案:

{
  "mcpServers": {
    "oncology-intelligence": {
      "url": "https://www.prognyx.com/api/mcp"
    }
  }
}

遠端端點

https://www.prognyx.com/api/mcpstreamable-http

它能做什麼

工具清單

工具(3)

🟢 唯讀🟡 寫入🔴 刪除⚪ 未知
🟢compare_trials(asset, indication)

Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.

輸入結構描述

{
  "type": "object",
  "properties": {
    "asset": {
      "type": "string",
      "maxLength": 80,
      "description": "Public asset or target, e.g. \"sotorasib\", \"KRAS G12C\", \"B7-H3\"."
    },
    "indication": {
      "type": "string",
      "maxLength": 80,
      "description": "Oncology indication, e.g. \"colorectal cancer\", \"NSCLC\"."
    }
  },
  "required": [
    "asset",
    "indication"
  ],
  "additionalProperties": false
}
🟢search_registry(query, limit)

Live landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.

輸入結構描述

{
  "type": "object",
  "properties": {
    "query": {
      "type": "string",
      "maxLength": 160,
      "description": "e.g. \"KRAS G12C\", \"Nuvalent\", \"claudin 18.2 gastric cancer\", \"NCT05132075\"."
    },
    "limit": {
      "type": "integer",
      "minimum": 1,
      "maximum": 25,
      "default": 10,
      "description": "Studies to return."
    }
  },
  "required": [
    "query"
  ],
  "additionalProperties": false
}
🟢search_briefings(query, limit)

Prognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.

輸入結構描述

{
  "type": "object",
  "properties": {
    "query": {
      "type": "string",
      "maxLength": 120,
      "description": "Drug, company, target or indication. Empty returns the latest."
    },
    "limit": {
      "type": "integer",
      "minimum": 1,
      "maximum": 20,
      "default": 5,
      "description": "Briefings to return."
    }
  },
  "additionalProperties": false
}

社群

為此伺服器評分

證據

近期觀測

已驗證未記錄版本3 個工具